Catalyst Wire Dossier Catalyst Wire Dossier

EB01 Cream

· Edesa Biotech Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EB01 Cream, covering 2024-11-14 to 2024-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis [Phase 2]

See pricing